Rights and permissions
About this article
Cite this article
Memantine cost saving in moderately-severe to severe AD. Pharmacoecon. Outcomes News 459, 5 (2004). https://doi.org/10.2165/00151234-200404590-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404590-00009